CompuNet Clinical Laboratories Introduces 'Schedule My Labs'
CompuNet Clinical Laboratories is excited to share the launch of Schedule My Labs, offering a customized and seamless appointment booking experience at its more than 30 patient service center locations.
Key Features
- Customizability: Tailor appointments to your needs for a smoother booking process
- Seamless Integration: Schedule My Labs complements My Labs Now Results Portal for a cohesive experience
- Improved Sign-In Stations: Larger kiosk stations are coming soon for better in-person visits
- Smooth Transition: Appointments after August 11 in our current platform, Solv, will be moved to Schedule My Labs by Patient Service Center management
Join us on August 12 for the future of appointment scheduling at CompuNet with Schedule My Labs. Schedule your appointment online.
Upcoming Changes In Chemistry
Policy Change: Add-on Testing for HCG and PCT
Due to the sensitivity of our Human chorionic gonadotropin (hCG) and Procalcitonin (PCT) assays performed in the CompuNet Chemistry lab, testing can no longer be added on to specimens that have been previously tested. When submitting a new order in Epic, it will require a new specimen collection. This policy change went into effect on July 26, 2023.
Methodology Change: Tumor Markers
CompuNet will be switching chemistry instrumentation and methodology for tumor marker testing later this fall. In general, tumor marker values from different assay methods and instruments are not interchangeable due to differences in calibration, antibody specificity, and assay design. Therefore, it is strongly recommended that clinicians re-establish baseline tumor marker levels on the new method for AFP, CEA, CA 125, CA 15-3 and CA 19-9. Prior to the methodology change, the laboratory will have a re-baseline period during which we will automatically perform and report results from both instrument platforms to help clinicians evaluate the differences between the methods. The re-baseline will be at no additional charge to the patient.
Back to the August 2023 issue of Premier Pulse